Introduction
Please join us for a 60-minute webinar presenting the latest information on Millipore’s Pandemic Preparedness Plans.
With the announcement of the H1N1 pandemic by the WHO, Millipore has proactively initiated a number of actions to prepare our organization for the upcoming influenza season. This webinar will outline our pandemic plan, answer common questions regarding activities we have undertaken to help ensure Business Continuity for our customers, and discuss Millipore’s involvement in supporting the manufacturing and approval of the H1N1 vaccine.
You can also learn more about our Pandemic Preparedness Program by clicking here.
When: October 15th at 9:00 A.M. EST
Agenda
- Status of Pandemic
- Review of Millipore’s Pandemic Preparedness Program
- Business Continuity Planning
- Capacity Planning
- Where to find updates and status
- Millipore’s Involvement with Pandemic Manufacturers
- Technical Activities
- Regulatory Activities
- Interactive Q&A Session
Presenters
Robert ShawProgram Director, Vaccines and Emerging Biotech
Mark Dyment
Demand Planning Manager
Maurice Phelan
Director, Global Compliance Services and Regulatory Affairs
